Celldex has stopped development of barzolvolimab in eosinophilic esophagitis (EoE) despite meeting its primary endpoint in a phase 2 trial. The biotech showed the candidate depletes mast cells in the ...
Marc Santos is a Guides Staff Writer from the Philippines. He's a seasoned writer with over four years of industry experience, and he is an enjoyer of all things difficult in gaming. If Marc's not ...
After three stressful years, Mark Sevillano Jr. felt like his life was falling into place. At the start of 2024, he began working out at the gym three days a week and eating healthier foods. “I felt ...
The Everdark Sovereign version of Fissure in the Fog has arrived in Elden Ring Nightreign, giving players the opportunity to take down an enhanced version of the ice dragon. As is to be expected from ...
FULLERTON, Calif. (KABC) -- The latest findings reveal esophageal cancer rates are up across the board. Many factors can raise your risk, including your line of work. A recently FDA-approved, ...
Firefighters were at Providence St. Jude Medical Center in Fullerton on Wednesday, July 23, being screened with new technology designed to screen for a pre-cancerous condition known as Barrett’s ...
Iceland's Reykjanes Peninsula experienced its 12th volcanic eruption in just over four years on Wednesday, as lava burst from a fissure following a series of earthquakes hours earlier. The Icelandic ...
A new, non-invasive test called ESOGuard is giving patients a better chance at surviving one of the deadliest cancers in the country. More than 22,0000 Americans are expected to be diagnosed with ...
Esophageal cancer is relatively rare, making up only 1% of all cancer diagnoses in the US. However, it is also one of the most deadly cancers — with a five-year survival rate of only 20%.
Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for which no effective targeted therapy exists. Patients need to rely on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results